Información de la publicación

Portal del Investigador > en > Publications > publication-detail

Incidence and general clinical features of giant cell arteritis in the ARTESER multicenter study

Other conference communications or articles related to authors from the University of Cantabria

Abatacetp in spanish patients with arthritis rheumatoid and interstitial lung disease. Multicenter study of 263 patients - Conference object
Biological therapy in atypical optic neuritis refractory to conventional treatment. A multicenter study with 19 patients. - Conference object
Diagnosis of behçet's disease: comparison of two sets of classification criteria. Application in 111 patients of a well-defined population - Conference object
Disease-related factors associated to atherosclerotic disease in axial spondyloarthritis. A mutlicenter study with 806 patients - Conference object
Incidence of first cardiovascular event in spanish patients with chronic inflammatory rheumatic diseases. Prospective data after five years of follow up - Conference object
Infliximab in refractory uveitis due to Behçet's disease: long term follow-up and therapy optimization. Multicenter study of 103 caucasian patients - Conference object
Long-term follow-up of renal transplantation due to lupus nephritis. Single universitary center experience - Conference object
Ocular involvement and treatment in sarcodosis. Study of 41 patients of a series of 383 patients from a single university hospital - Conference object
Ocular manifestations in inflammatory bowel disease. Study of 1442 patients from a single referral center - Conference object
Ocular scleral pathology and immune-mediated inflammatory diseases. Study of 170 patients from a single universitary center - Conference object
Ongoing vascular 18F-FDG uptake despite clinical remission in patients receiving tocilizumab for large vessel vasculitis-giant cell arteritis: single universitary center experience of 30 patients - Conference object
Response to Tocilizumab in large vessel vasculitis according to the extent of Baseline 18F-FDG vascular uptake - Conference object
Rituximab in the treatment of interstitial lung disease associated with autoimmune diseases: experience from a single referral center - Conference object
Subclinical atherosclertoic disease in ankylosing spondylitis and non-radiographic axial spondyloarthritis: a multicenter study with 806 patients. - Conference object
Systemic treatment in behçet's disease according to clinical phenotypes. study of 111 patients - Conference object
Systemic treatment in sarcoidosis. study of 377 patients from a single university hospital - Conference object
Treatment with Certolizumab Pegol in refractory uveitis secondary to inmune-mediated inflammatory diseases. Multicenter study of 39 patients - Conference object
Unsupervised molecular profile clustering in the serum of rheumatoid arthritis patients identifies groups with differential CV-risk SCORE: modulation by biological therapies - Conference object
Differential gender impact in the quality of life of patients with rheumatoid arthritis. Comprehensive study including clinical, comorbidity and psicho-social variables - Conference object
HLA-DRB1*01 is associated with Henoch- Schönlein purpura in the spanish population - Conference object
Adalimumab therapy improves insulin sensitivity in non-diabetic psoriatic patients: a 6-month prospective study - Conference object
Protective effect of the IL33 rs3939286 gene polymorphism in the development of subclinical atherosclerosis in patients with rheumatoid arthritis - Conference object
Osteoprotegerin CGA haplotype protection against cerebrovascular complications in anti-CCP negative patients with rheumatoid arthritis - Conference object
Osteprotegerin concentrations are independently related to established cardiovascular disease in rheumatoid arthritis - Conference object
Assessment of osteoarthritis candidate genes in a meta-analysis of nine genome-wide association studies - Article
HLA-B*08 identified as the most prominently associated major histocompatibility complex locus for anti-carbamylated protein antibody-positive/anti-cyclic citrullinated peptide-negative rheumatoid arthritis - Article
Integrative analysis reveals a molecular stratification of systemic autoimmune diseases - Article
Diagnosis of giant cell arteritis in spain: data from the arteser registry - Conference object
High dose intravenous methylprednisolone induces rapid improvement of visual acuity in non-infectious uveitis of different immune mediated inflammatory diseases - Conference object
Rapid improvement in cystoid macular edema with high dose intravenous methylprednisolone in non-infectious uveitis of different immune mediated inflammatory diseases - Conference object
Chemoprophylaxis in latent tuberculosis associated with rheumatic immune-mediated diseases. Study of 240 patients from a single university hospital - Conference object
Hydroxycloroquine-induced atrioventricular block in inmune-mediated diseases. Single university center study of 293 patients - Conference object
Treatment of ocular sarcoidosis: study of 65 patients of a series of 384 patients from a single university hospital - Conference object
Epidemiology of latent tuberculosis infection in patients with rheumatic immune-mediated diseases: single university study of 1117 patients - Conference object
Epidemiology and clinical features of ophthalmological manifestations in behçet?s disease: study of 50 patients of a series of 120 patients in a region in northern spain - Conference object
COVID 19 infection in patients with rheumatic immune-mediated diseases in a single university hospital: matched case-control study - Conference object
Clinical associations of Anti-Ro52 antibodies in patients with systemic autoimmune rheumatic diseases - Conference object
Contribution of scleroderma/myositis-related antibodies detected by immunoblot to the diagnosis of systemic autoimmune rheumatic diseases in 134 patients from a single referral center - Conference object
Comparison of diagnostic criteria in behçet's disease and sensitivity in diagnosing severe manifestations - Conference object
Uveitis and inflammatory bowel disease: study of 1449 patients from a single university center - Conference object
Ocular scleral pathology: clinical features and systemic treatment in 175 patients from a single university center - Conference object
Uveitis in 406 patients with psoriatic arthritis: epidemiology, clinical characteristics and relationship with biological treatment. Study of a single university center - Conference object
Uveitis in 301 patients with axial spondyloarthritis of a single university center: epidemiology, clinical features and biological treatment - Conference object
Clinical, laboratory and imaging outcomes in tocilizumab-treated patients with large vessel-giant cell arteritis according to early onset therapy - Conference object
Giant cell arteritis subtypes: data from the arteser registry - Conference object
Effectiveness of tocilizumab in cranial and extracranial phenotypes of giant cell arteritis: multicenter study of 471 cases - Conference object
Treatment of giant cell arteritis in the ARTESER multicenter study of 1675 patients - Conference object
Effectiveness of Tocilizumab in the Visual Involvement of Giant Cell Arteritis: Multicenter Study of 471 Patients of Clinical Practice - Conference object
Decrease of angiogenic t cells associated to the presence of interstitial lung disease in patients with connective tissue diseases - Conference object
Severity factors of Covid-19 infection in rheumatic immune-mediated inflammatory diseases: study in a single university hospital - Conference object
Severe respiratory infections in rheumatoid arthritis patients with biologic therapy: comparative study between vaccinated and non vaccinated patients - Conference object
Abatacept in usual and in non-specific interstitial pneumonia associated to rheumatoid arthritis. National multicenter study of 190 patients - Conference object
Comparative study on anti-TNF vs Tocilizumab for treatment of refractory uveitic cystoid macular edema due to behcet´s disease: multicenter study of 49 patients - Conference object
Tocilizumab in caucasian patients with takayasu arteritis: multicenter study of 54 patients - Conference object
Biological therapy in refractory neurobehçet´s disease. Multicenter study of 42 patients - Conference object
Efficacy of tocilizumab in conventional treatment-refractory adult-onset Still's disease: multicenter retrospective open-label study of thirty-four patients. - Article
Lack of replication of an association between anti-citrullinated fibrinogen and subclinical atherosclerosis in patients with rheumatoid arthritis - Article
Bone morphogenetic protein and activin membrane-bound inhibitor, a transforming growth factor ß rheostat that controls murine treg cell/Th17 cell differentiation and the development of autoimmune arthritis by reducing interleukin-2 signaling - Article
Pleuroparenchymal fibroelastosis: a special clinical situation in patients with interstitial lung disease associated with connective tissue diseases. Descriptive study from a referral centre - Conference object
Microvascular involvement in behcet's disease: study of nailfold capillaroscopy in patients from a national referral center - Conference object
Anti-TNF versus anti-IL6 receptor antagonist therapy in severe ocular involvement in behcet's disease - Conference object
Relationship between baseline characteristics of rheumatoid arthritis and types of mortality: study of cohort followed prospectively - Conference object
Mortality in rheumatoid arthritis: changing causes and predictive factors. Study of a cohort followed prospectively - Conference object
Uveitis in psoriatic arthritis: study of 406 patients in a single university center - Conference object
Herpes Zoster in rheumatoid arthritis: prospective single university center study - Conference object
Association between cumulated hydroxychloroquine in systemic lupus erythematosus and development of cardiac conduction alterations: a multiple logistic regression analysis - Conference object
Distinct clinical and therapeutic features between parenchymal and non-parenchymal manifestations in neurobehcet's disease - Conference object
Prevalence, phenotypical clinical clusters and treatment of Neurobehcet's Disease: Study in Northern Spain - Conference object
Biological therapy in neurosarcoidosis: study of 30 patients from a series of 234 systemic sarcoidosis from a university hospital - Conference object
Increased risk of hepatotoxicity with DMARDS in patients with previous liver toxicity with isoniazid: study in a single university hospital - Conference object
Predictive severity factors of COVID-19 in patients with rheumatic immune mediated diseases - Conference object
JAKINIB in refractory giant cell arteritis. National multicenter study of 15 cases and literature review - Conference object
Tocilizumab in large-vessel giant cell arteritis and takayasu arteritis: multicentric observational comparative study - Conference object
Assessment of common femoral vein intima-media thickness by ultrasound in behcet's disease: comparative study of patients with or without vascular involvement in a national referral center - Conference object
Monocyte chemoattractant protein-1, vascular cell adhesion protein-1 and asymmetric dimethylarginine as potential biomarkers of interstitial lung disease associated with RA - Conference object
Increase of intercellular adhesion molecule-1 linked to lung damage of interstitial lung disease in patients with autoimmune diseases - Conference object
Epidemiology of behcet's disease in northern Spain - Conference object
Increase of serum endothelin-1 levels in patients with interstitial lung disease associated with autoimmune diseases - Conference object
Nuclear factor of activated T cells cytoplasmic 1 as a potential biomarker of increased cardiovascular risk in patients with early rheumatoid arthritis - Conference object
Silencing of WISP-2 induces inflammatory mediators and catabolic factors in cartilage - Conference object
Janus kinase inhibitors in severe and refractory inflammatory ocular pathology. Cases reports and literature review - Conference object
Intravenous versus subcutaneous tocilizumab in a series of 471 patients with giant cell arteritis - Conference object
Assessing the effectiveness of tocilizumab in newly diagnosed giant cell arteritis versus refractory/recurrent giant cell arteritis in clinical practice - Conference object
Assessing the effectiveness of tocilizumab in giant cell arteritis by PET: multicenter study of 101 patients of clinical practice - Conference object
Classifying extracranial large-vessel giant cell arteritis using the new 2022 American College of Rheumatology/EULAR classification criteria: comment on the article by Ponte et al. - Article
The genetic contribution of inflammation to the increased risk of cardiovascular disease in rheumatoid arthritis: comment on the article by Yuan et al - Article
2015 Recommendations for the Management of Polymyalgia Rheumatica: a European League Against Rheumatism/American College of Rheumatology Collaborative Initiative - Article
Therapeutic effects of anti-bone morphogenetic protein and activin membrane-bound inhibitor teatment in psoriasis and arthritis - Article
SJOGRENSER registry: prospective evaluation of a cohort of patients with primary Sjögren's syndrome after 8 years of follow-up - Conference object
Cardiovascular damage in systemic lupus erythematosus occurs at early stages of the disease. chronological analysis of damage accrual in a large cohort from the spanish society of rheumatology lupus registry (RELESSER) - Conference object
Changes in the causes and predictors of lupus mortality in spain through the last decades: data from the RELESSER registry - Conference object
18f-FDG-PET/CT for giant cell arteritis detection of large vassel vasculitis: what should we take into consideration? Analytical study of the arteser resgistry - Conference object
ANCA-associated vaculitis incidence in norther spanish health region - Conference object
C5 as a genetic marker for discriminating between IgA vasculitis and IgA nephropathy? - Conference object
Biologic use regulates the impact of inflammation on ischemic cardiovascular risk in rheumatoid arthritis - Conference object
Aortitis and periaortitis spectrum in 135 patients from a single referral centre - Conference object
Aortic aneurysms in a multicenter cohort of 196 patients with aortitis related to giant cell arteritis treated with tocilizumab - Conference object
Anti-HMGCR autoantibody levels in the follow-up of statin-induced immune-mediated necrotizing myopathy: multicentric study of 24 patients - Conference object
Antibody predictors of prognosis in a large multi-centre cohort of idiopathic inflammatory myopathy associated interstitial lung disease - Conference object
ANCA-associated vasculitis and renal disease in a multidisciplinary outpatient clinic in Northern Spain - Conference object
Case series of 6 patients exhibiting myositis as a rheumatologic adverse events related to cancer immunotherapy in twot spanish hospitals - Conference object
Characterization of interstitial pheumonia with autoimmune features (IPAF) in a national referral centre - Conference object
A comparative study of cryofibrinogenemia before and after COVID-19 Era - Conference object
Comparision of treatment with adalimumab, infliximab and certolizumab in refractory cystoid macular edemea due to Behçet disease - Conference object
Concordance between the 1990 ACR classification criteria and the new 2022 ACR/EULAR 2022 criteria in giant cell arteritis - Conference object
Coronary calcium and carotid artery stiffness as predictors of cardiovascular events and mortality in patients with rheumatoid arthritis: a 10-year prospective follow-up study - Conference object
Deciphering rheumatoid arthritis-associated interstitial lung disease phenotypes using unsupervised hieratchical clustering analysis: results from a large collaborative international study - Conference object
Determining the ECG Cutt-Off point in systemic lupus erythematosus patients undergoing hydroxychloroquine therapy - Conference object
Efficacy of abatacept in rheumatoid arthritis- associated usual interstitial pneumonia. National multicenter study of 2023 patients during a long-term follow up - Conference object
Efficacy of filgotinib in patients with rheumatoid arthritis: week 156 results from a long-term extension study - Conference object
Eosinophilic granulomatosis with polyangiitis: clinical suspicion red flags identification by a systematic literature review and multidisciplinary expert consensus - Conference object
Epidemiology and predictors of relapse in giant cell arteritis: results of the ARTESER register - Conference object
E-selectin, ICAM-1 and ET-1 biomarkers address the concern of the challenging diagnosis of interstitial lung disease in patients with autoimmune diseases - Conference object
Molecular characterisation of remission and lupus low disease activity state (LLDAS) by whole-blood transcriptome-based pathways in pan-european systemic lupus erythematosus cohort - Conference object
Methotrexate use associates with ischemic cardiovascular risk reduction in males but not females with rheumatoid arthritis - Conference object
Long-term efficacy and safety of risankizumab for active psoriatic arthritis: 148-week results from the KEEPsAKE 2 Trial - Conference object
Janus Kinase inhibitors in giant cell arteritis in clinical practice. Real-world clinical practice study and literature review - Conference object
JAK Inhibitors in rheumatoid arthritis-interstitial lung disease. National multicenter study of 73 patients, 55 of baricitinib - Conference object
Intravenous immunoglobulins in the treatment of idiopathic inflammatory myopathies in a region of northern spain: analysis by subtypes - Conference object
Identification of clinical phenotypes in sarcoidosis using a cluster analysis - Conference object
Incidence of neurobehçet disease in northern Spain 1999-2019. A population-based study - Conference object
Identification of clinical phenotypes in Behçet's disease using a cluster analysis - Conference object
HDL-Cholesterol efflux and the complement system are linked in systemic lupus erythematosus - Conference object
Glucocorticoids use is a major driver of self-perceived depression in systemic lupus erythematosus: insights from a large, prospective and multicenter study using RELESSERPROS register's database - Conference object
Factors associated with the need for assisted reproductive therapies in a spanish cohort of patients with rheumatic diseases - Conference object
Neurosarcoidosis disease epidemiology. University hospital in northern Spain 1999-2019 - Conference object
NFKB1 and NFKBIA: relevant players in the pathogenesis of IgA vasculitis? - Conference object
Patients with systemic lupus erythematosus: a comparative study between two large, multi-centric, spanish and argentinian registers, focused on outcomes differences - Conference object
Real world data on antifibrotics in rheumatoid arthritis-interstitial lung disease. National multicenter study of 73 patients - Conference object
Prevalence and screening strategy for latent tuberculosis infection in patients with rheumatic immune-mediated diseases - Conference object
Proposal for defining moderate and severe activity states in systemic lupus erythematosus. Impact on flares and other outcomes - Conference object
Relapse in giant cell arteritis treated with tocilizumab. Predictive factors - Conference object
Refractory inflammatory ocular pathology and treatment with Janus Kinase inhibitors. Multicenter study and literature review - Conference object
Relation between positive MPO-ANCA antibodies and: associated diseases, anca-associated vasculitis specificty, severity and prognosis. Study from a single university hospital - Conference object
Remission in anti-HMGCR positive immune-mediated necrotizing myopathy without the use of glucocorticoids: a multicentric study of 24 patients - Conference object
Revised IWOS criteria for ocular sarcoidosis: a 2019 review of the 2009 criteria in a study of 384 patients from a single university hospital - Conference object
Role of periostin in the pathophysiology and accurate diagnosis of interstitial lung disease associated with autoimmune diseases - Conference object
Sex differences in giant cell arteritis: data from the ARTESER registry - Conference object
SLESIS-R: an improved score for prediction of serious infection in patients with systemic lupus erythematosus based on the RELESSER prospective cohort - Conference object
Statin use attenuates the impact of systemic inflammation on ischemic cardiovascular risk in patients with rheumatoid arthritis - Conference object
Subcutaneus vs intravenous abatacept in rheumatoid arthritis-interstitial lung disease. National multicenter study of 509 patients - Conference object
Upadacitinib in refractory psoriatic arthritis. Multicenter study of 134 patients in clinical practice - Conference object
Visual manifestations in giant cell arteritis: identification of risk factors from the ARTESER registry - Conference object
Window of opportunity in the treatment of rheumatoid arthritis-interstitial lung disease with abatacept. National multicenter study of 509 patients - Conference object
Association of combined anti-Ro52/TRIM21 and anti-Ro60/SSA antibodies with increased Sjögren disease severity through interferon pathway activation - Article
Systemic sclerosis patients with antitopoisomerase antibodies showed significant association with CCR6 polymorphisms - Conference object
Analgesic and anti-hyperalgesic effects of deep dry needling therapy in fibromyalgia patients - Conference object
Efficacy of anakinra in refractory adult-onset stills disease: multicenter study of 41 patients - Conference object
A candidate gene approach identifies IL33 as a novel genetic risk factor for GCA - Conference object
Influence of the IL17A locus in giant cell arteritis susceptibility. - Conference object
Efficacy of tocilizumab in patients with uveitis refractory to other biologic drugs: a multicenter study on 31 cases - Conference object
Golimumab as an alternative therapy in patients with Uveitis Refractory to other anti-TNF drugs. Multicenter study of 29 cases - Conference object
Efficacy of certolizumab in patients with refractory uveitis to other biologic therapy. Study of 7 cases - Conference object
Intravenous methylprednisolone pulse therapy in severe inflammatory eye sisease. A multicenter study - Conference object
Tocilizumab in giant cell arteritis: multicenter open-label study of 22 patients - Conference object
An immunochip study confirms a strong contribution of HLA class I and II genes in the susceptibility to giant cell arteritis - Conference object
Clinical and temporal characterization of Anti-Jo-1 positive anti-synthetase syndrome: preliminary results of an international multicentre study - Conference object
Heterogeneity in cardiovascular risk factors, event rates and ra disease characteristics among patients with rheumatoid arthritis across 10 countries - implications for CV Risk Assessment. - Conference object
Applicability of the 2006 European League Against Rheumatism (EULAR) criteria for the classification of Henoch-Schönlein purpura. An analysis based on 766 patients with cutaneous vasculitis. - Conference object
Proteinase K-like serine protease PCSK9 Influence on the dyslipidemia and endothelial dysfunction observed in rheumatoid arthritis patients - Article
Analysis of the fibromyalgia rapid screening tool spanish version to detect fibromyalgia in primary health care centers - Conference object
Assessment of the spanish version of the american college rheumatology preliminary diagnostic criteria for fibromyalgia - Conference object
Cutaneous vasculitis associated with severe bacterial infections. Study of 27 patients from a series of 766 cutaneous vasculitis - Conference object
Drug-associated cutaneous vasculitis: study of 239 patients from a single referral center - Conference object
Comparative study of infliximab versus adalimumab in patients with refractory uveitis due to behçet's disease. multicenter study of 125 cases. - Conference object
Prospective study of the effect of treatment with Adalumumab in angiogenesis in moderate or severe psoriasis for a period of 6 months - Conference object
Tocilizumab compared with anakinra in refractory adulto-onset still’s disease. Multicenter study of 75 patients - Conference object
Protective role of the vitamin D Receptor Apai (rs7975232) polymorphism against subclinical atherosclerosis in patients with rheumatoid arthritis from northern spain - Article
Lack of association between ZHX2, lepr, gckr and ASCL1 and carotid intima-media thickness, carotid plaques and cardiovascular disease in patients with rheumatoid arthritis - Conference object
Lack of replication of the association between anti-citrullinated fibrinogen and subclinical atherosclerosis in patients with rheumatoid arthritis - Conference object
Relapses and predictive factors in Henoch-Schönlein purpura. Study of 417 patients - Conference object
Serum cathepsin S and cystatin C relation with carotid subclinical atheromatosis in rheumatoid arthritis patients - Conference object
Insulin resistance is not associated with increased risk of subclinical atheromatosis in patients with systemic lupus erythematosus from northern spain - Conference object
Identification of genetic factors associated with clinical manifestations of giant cell arteritis through a stratified large-scale analysis - Conference object
Lack of association of a 6.7 Kbp deletion of LILRA3 with giant cell arteritis - Conference object
Tocilizumab in refractory uveitis associated with behçet?s disease. Multicenter study of 7 patients - Conference object
Treatment of refractory non-infectious aortitis: tocilizumab compared to antitnf alfa agents. Multicenter study of 44 patients - Article
Tocilizumab in refractory takayasu arteritis. A multicenter study - Conference object
A meta-immunochip analysis suggests IL12B as a common susceptibility factor for large-vessel vasculitides - Conference object
Tocilizumab in refractory uveitis associated to juvenile idiopathic arthritis. Multicenter study of 13 cases - Conference object
Timing of onset and cluster with other manifestations influence the spectrum of arthritis in anti Jo-1 positive antisynthetase syndrome: results from a multicenter, international, retrospective study - Conference object
Clinical follow-up predictors of disease pattern change in anti Jo-1 positive antisynthetase syndrome: results from a multicenter, international and retrospective study - Conference object
Long term biological therapy in uveitis refractory due to Behçet’s disease. Multicenter study of 165 patients. - Conference object
Identification of IRX1 as a risk locus for rheumatoid factor positivity in rheumatoid arthritis in a genome-wide association study - Article
Chronological analysis of damage accrual in patientes with systemic lupus erythematosus: results from the spanish registry of patients with SLE of the Spanish Society of Rheumatology (RELESSER) - Conference object
Biological treatments in primary sjögren syndrome - Conference object
EULAR Primary SjöGren?s Syndrome Disease Activity Index (ESSDAI), Results from the National Registry of the Spanish Society of Rheumatology (SJÖGRENSER) - Conference object
Clinical and immunological characteristics of primary sjogren´s syndrome in men - Conference object
Genome-wide pathway analysis reveals that VEGF genetic pathway is associated with oral ulcers in systemic lupus erythematosus - Conference object
Cross-disease meta-analysis of genome-wide association studies for systemic sclerosis and rheumatoid arthritis reveals irf4 as a new common susceptibility locus - Article
Paraoxonase 1 activity is modulated by the rs662 Polymorphism and IgG Anti-High-Density lipoprotein antibodies in patients with rheumatoid arthritis: potential implications for cardiovascular disease - Article
Golimumab in refractory uveitis associated to juvenile idiopathic arthritis. Multicenter study of 7 cases and literature review - Conference object
Combined-phenotype meta-GWAS in systemic sclerosis and rheumatoid arthritis identifies IRF4 as a new common susceptibility locus - Conference object
New insights into the pathogenesis of giant cell arteritis through a genome-wide association study - Conference object
A combined large scale meta-analysis identifies COG6 as a novel shared risk locus for rheumatoid arthritis and systemic lupus erythematosus - Conference object
Tocilizumab for uveitic cystoid macular edema refractory to other synthetic and biological immunosuppressive drugs. Multicenter study of 25 patients - Conference object
Utility of relative cardiovascular risk score scales and vascular age predictors in patients with reumathoid arthritis under 50 years of age - Conference object
Utility of relative cardiovascular risk score scales in patients under the age of 50 and its association with the presence of carotid atherosclerosis in the ultrasound - Conference object
Comparison between carotid plaque and carotid intima-media thickness to detect subclinical atherosclerosis in rheumatoid arthritis - Conference object
Comparison between intima-media thickness and coronary artery tomography in subclinical atheroesclerosis detection in rheumatoid arthritis - Conference object
Comparison between carotid ultrasonography and coronary artery calcification score to detect subclinical atherosclerosis in rheumatoid arthritis - Conference object
Vaccination program to prevent hospital admissions due to serious respiratory infections in rheumatoid arthritis patients. Prosprective study of 294 patients - Conference object
Incretin Axis in non diabetic rheumatoid arthritis patients - Conference object
Interaction between antibodies to paraoxonase 1 and PON1 rs662 polymorphism: new clues to understand HDL dysfunction and oxidative stress in rheumatoid arthritis - Conference object
Assessment of serum calprotectin and osteoprotegerin levels in a cohort of spanish patients with axial spondyloarthritis - Conference object
Abatacept in rheumatoid arthritis with interstitial lung disease: a multicenter study of 55 patients - Conference object
Optimization of adalimumab on refractory uveitis of behcet´s syndrome. Multicenter study of 23 patients - Conference object
Adalimumab versus infliximab in cystoid macular edema of uveitis associated to behçet disease. multicenter study of 34 patients - Conference object
Anti-IL6-R Tocilizumab in refractory uveitis associated with behçet´s disease. Multicenter study of 11 patients - Conference object
Biologic therapy in severe Peripheral Ulcerative Keratitis (PUK). Multicenter study of 27 patients - Conference object
Is the homeostatic model assessment of insulin resistance a poor predictor of cardiovascular disease in rheumatoid arthritis? Comment on the article by Giles et al. - Article
Mycobacterial infection in systemic lupus erythematosus: clinical significance and associated factors. Data from the Registry of Patients with SLE of the Spanish Society of Rheumatology (RELESSER) - Conference object
Amylin in the insulin resistance of patients with rheumatoid arthritis - Conference object
Epithelial neutrophil-activating peptide 78/C-X-C motif chemokine 5 in the insulin resistance of patients with rheumatoid arthritis - Conference object
Performance of cardiovascular risk age and vascular age estimations in predicting cardiovascular events in rheumatoid arthritis - Conference object
Use of positron emission tomography for the diagnosis of aortitis: a study of 170 patients from a single center - Conference object
Anti-interleukin-6 receptor tocilizumab for severe juvenile idiopathic arthritis-associated uveitis refractory to anti-tumor necrosis factor therapy: a multicenter study of twenty-five patients - Article
Response to Abatacept of different patterns of interstitial lung disease in rheumatoid arthritis: multicenter study of 63 patients - Conference object
Short and long-term follow-up with tocilizumab in giant cell arteritis: national multicenter study of 49 patients of clinical practice - Conference object
Comparison between giacta trial and a multicenter series of giant cell arteritis patients from clinical practice with tocilizumab - Conference object
Extension of affected vascular territories in secondary aortitis is associated to different clinical subtypes? - Conference object
Rapid improvement with tocilizumab in refractory and severe uveitic cystoid macular edema - Conference object
Beneficial effect of anti-IL-6 blockade on insulin resistance and insulin sensitivity in patients with rheumatoid arthritis - Conference object
Protein tyrosine phosphatase non-receptor 22 / C-Src tyrosine kinase complex down-regulated in patients with rheumatoid arthritis - Conference object
Anti-TNF[alfa] versus Rituximab in refractory peripheral ulcerative keratitis associated to rheumatic diseases: multicenter study of 24 patients - Conference object
Golimumab versus tocilizumab in uveitis related to refractory juvenile idiopathic arthritis: national multicenter study of 33 patients - Conference object
The efficacy of tofacitinib in patients with rheumatoid arthritis stratified by baseline body mass index - Conference object
Rituximab in rheumatoid arthritis with interstitial lung disease: a multicenter study of 32 patients - Conference object
Circulating mirnas as potential biomarkers of cardiovascular disease in rheumatoid arthritis patients - Conference object
Increased prevalence of subclinical atherosclerosis in moderate-severe plaque psoriasis patients - Conference object
Anti-IL6-receptor Tocilizumab in refractory uveitis associated to extraocular manifestations in patients with Behçet´s Disease: multicenter study - Conference object
Long term follow-up and optimization of infliximab in refractory uveitis of behçet's disease: multicenter study of 103 cases - Conference object
Adalimumab therapy optimization in refractory uveitis due to behçet's disease after achieving remission. Interventional versus control group - Conference object
Apremilast for refractory mucocutaneous ulcers of behçet's disease: national multicenter study of 14 cases - Conference object
Short and long-term follow-up of tocilizumab for severe juvenile idiopathic arthritis-associated uveitis - Conference object
HLA-DRB1 association with Henoch-Schonlein purpura - Article
Multi-omics analysis identifies a gene signature associated with the clinical response to anti-tnf therapy in rheumatoid arthritis - Conference object
Immune-related adverse events associated with immunotherapy in solid organ tumors. Study of 102 cases from a referral single center for last 3 years - Conference object
Factors associated with the developement of severe respiratory infections in patients with rheumatoid arthritis included in a vaccination program - Conference object
Long-term survival of renal transplantation due to lupus nephritis. Comparative study with non-autoimmune transplantation. Study from a single center - Conference object
Classic and atypical polymyalgia rheumatica, are different syndromes? Study of 93 patients with PET/CT from a single center - Conference object
Development of a predictive model of radiological damage in patients with rheumatoid arthritis based on artificial intelligence - Conference object
Implication of CXCL5 (epithelial neutrophil-activating peptide 78) in the development of insulin resistance in patients with rheumatoid arthritis - Conference object
The relationship between lipid profile changes and inflammation across the phase 3 Sarilumab Rheumatoid Arthritis (RA) developmental program - Conference object
Long-term survival of renal transplantation in rapidly progressive glomerulonephritis (RPGN). Study of 43 cases from a single center - Conference object
Apremilast in refractory oral and/or genital ulcers in behçet's disease. Multicenter study of 37 cases - Conference object
Comparative study of infliximab versus adalimumab in refractory uveitis due to behçet's disease. National multicenter study of 177 cases - Conference object
Optimization protocol for adalimumab treatment in refractory uveitis due to behçet's disease - Conference object
Omentin-1: potential biomarker of cardiovascular risk in axial spondyloarthritis? A serological and genetic study - Conference object
Predictive factors of a positive PET/CT Scan for vascular involvement in patients with polymyalgia rheumatica - Conference object
Ocular and systemic features in 262 patients with systemic sarcoidosis and its correlation with iwos criteria - Conference object
Anti-IL6-Receptor Tocilizumab in graves' orbitopathy. multicenter study of 46 patients - Conference object
Infliximab therapy in refractory retinal vasculitis of behcet's disease,short and long-term follow-up. Multicenter study of 72 patients - Conference object
Treatment of refractory cystoid macular edema to conventional immunosuppressive therapy: tocilizumab Vs Anti-TNF-Alpha. Multicenter study of 59 patients - Conference object
High dose intravenous methylprednisolone induces rapid improvement in severe non-infectious uveitis. A multicenter study of 120 patients - Conference object
Refractory and severe uveitic cystoid macular edema improves with tocilizumab in different immune mediated diseases - Conference object
Herpes Zoster in rheumatoid arthritis. prospective single center study of 390 ra patients for 5 years - Conference object
Apremilast as treatment of refractory skin lupus lesions - Conference object
Giant cell arteritis in treatment with tocilizuma, evolution of vascular FDG uptake on PET/CT - Conference object
Clinical and anatomical correlation in patients with polymyalgia rheumatica by 18F-FDG PET/TC. study of 75 patients from a single referral center - Conference object
Tocilizumab in giant cell arteritis. National multicenter study of 134 patients of clinical practice - Conference object
Extension of extracranial vessel involvement in patients with giant cell arteritis - Conference object
Comparison between tocilizumab prescribed as monotherapy versus combined with conventional immunosuppressant agents in giant cell arteritis patients - Conference object
Utility of tocilizumab in visual affection of patients with Giant Cell Arteritis - Conference object
A multicenter series of giant cell arteritis patients from clinical practice in treatment with Tocilizumab compared with Giacta trial - Conference object
Long-term survival in lung transplantation for interstitial lung disease due to rheumatic systemic diseases. Study of 26 cases of a single center - Conference object
Consideration of antisynthetase syndrome features in classifying patients as having idiopathic inflammatory myopathy: comment on the article by Lundberg et al. - Article
Cardiovascular safety during treatment with baricitinib in rheumatoid arthritis - Article
Identification of a 3'-untranslated genetic variant of RARB associated with carotid intima-media thickness in rheumatoid arthritis: a genome-wide association study - Article
Comparative Study of Infliximab Versus Adalimumab in Refractory Uveitis Due to Behçet's Disease: National Multicenter Study of 177 Cases - Article
Efficacy of tocilizumab in giant cell arteritis, independent of the time of disease evolution - Conference object
Optimization of tocilizumab therapy in giant cell arteritis: a multicenter real life study of 134 patients - Conference object
Response to tocilizumab in patients with giant cell arteritis, according to ischemic vs systemic symptoms - Conference object
Tocilizumab in aortitis: a multicenter study of 79 patients - Conference object
Tocilizumab in giant cell arteritis: route of administration: intravenous or subcutaneous - Conference object
Tocilizumab in giant cell arteritis: the safest and most effective initial dose of prednisone - Conference object
Disease activity influences cardiovascular risk reclassification based on carotid ultrasound in patients with psoriatic arthritis - Conference object
Phenotype-based clustering along with analysis of molecular profile might help to define precise CV-risk profiles in RA patients - Conference object
Endothelial progenitor cells in the pathophysiology of interstitial lung disease associated with rheumatoid arthritis - Conference object
Systemic and ocular sarcoidosis study of 381 patients from a single universitary centre in the last 20 years - Conference object
Application of different sets of classification/diagnostic criteria for polymyalgia rheumatica: single center study of 100 patients - Conference object
Vaspin rs35262691 is associated with atherosclerotic disease in axial spondyloarthritis patients - Conference object
Influence of steroid treatment on 18F-FDG PET/CT accuracy to detect vascular and musculoeskeletal involvement in patients with polymyalgia reumatica - Conference object
Epidemology, clinical features and relationship to biological therapy of uveitis in axial spondyloarthritis: single center university study - Conference object
Biological therapy in non ischaemic optic neuritis associated to immune-mediated inflammatory diseases: multicenter study - Conference object
Certolizumab therapy in patients with uveitis during pregnancy: multicenter study - Conference object
Glucocorticoid dose is progressively reduced in patients with RA Receiving Sarilumab: results from the open-label EXTEND study - Conference object
Long-term follow-up of anti-il6-receptor tocilizumab in refractory uveitis in patients with behçet disease: multicenter study of 14 patients in clinical practice - Conference object
Biological therapy in neurobehçet: multicenter study of 31 patients - Conference object
Apremilast in combination vs monotherapy for refractory oral and/or genital ulcers in behçet´s disease: national multicenter study of 51 cases - Conference object
Ocular scleral pathology and relationship with autoimmune diseases: study of 101 patients from a single universitary centre - Conference object
The Spectrum of Interstitial Lung Disease Associated with Autoimmune Diseases: Data of a 3-Year-Prospective Study from a Referral Center of Lung Transplantation - Conference object
Abatacept in rheumatoid arthritis with interstitial lung disease: a retrospective multicenter study of 263 patients - Conference object
Long-term survival in lung transplantation and allograft rejection in patients with interstitial lung disease related with rheumatoid arthritis: study from a single referral center - Conference object
Consensus statement and recommendations on methotrexate use in combined therapy with biological or targeted synthetic disease modifying drugs in patients with rheumatoid arthritis - Conference object
Uveitis in 320 patients with psoriatic arthritis. Epidemiology, clinical features and biological treatment: study from a single university center - Conference object
Real-world comparative study of Methotrexate vs Tocilizumab in patients with giant cell arteritis with large vessel involvement - Conference object
Therapeutic effects of anti-bone morphogenetic protein and activin membrane-bound inhibitor treatment in psoriasis and arthritis - Article

Congress: ACR Convergence (2021)

Publisher: John Wiley and Sons Ltd

Year of publication: 2021

No. of pages: 3

Publication type: Conference object

ISSN: 2326-5205,2326-5191

Authorship

SÁNCHEZ-COSTA, JESÚS T.

MELERO-GONZÁLEZ, RAFAEL B.

FERNÁNDEZ-FERNÁNDEZ, ELISA

SILVA-DIAZ, MARÍA T.

BELZUNEGUI, JOAQUÍN M.

MORIANO, CLARA

SÁNCHEZ, JULIO

LLUCH, JUDIT

CALVO, ITZIAR

ALDASORO, VICENTE

ABASOLO, LYDIA

JAVIER LORICERA GARCIA

RUÍZ-ROMÁN, ALBERTO

CASTAÑEDA, SANTOS

MOYA, PATRICIA

GARCIA-VILLANUEVA, MARÍA J.

NAVARRO-ANGELES, VANESSA A.

GALISTEO, CARLES

MIGUEL ANGEL GONZALEZ-GAY MANTECON

RICARDO BLANCO ALONSO

Download reference

Bib Ris

Back

Researchers portal

Portal del personal investigador

Incidence and general clinical features of giant cell arteritis in the ARTESER multicenter study

Authorship

Download reference